top
Search terms
Results 1 - 10 of 29 - ordered by :
Pages: 1 2 3
Escardio

Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care – although a ...

Date : 28/08/2016
Escardio

Sweden is unique among countries in having comprehensive and high-quality cardiovascular registry data, says Prof. Omerovic, allowing a relatively large number of patients to be investigated over a ...

Date : 28/05/2019
Escardio

Worsening symptoms and signs of heart failure (WHF) in patients admitted to a hospital is a common sign of treatment failure and can lead to long-term consequences for the patient, including longer ...

Date : 17/05/2014
Escardio

“Contrary to what has been believed for decades,” says Dr. Mente, “the Prospective Urban Rural Epidemiology (PURE) study revealed that a high-carbohydrate diet increases the risk of ...

Date : 29/08/2018
Escardio

Double blind controlled trials have shown that CoQ10 improves symptoms, functional capacity and quality of life in patients with heart failure with no side effects. The primary endpoint was time to ...

Date : 25/05/2013
Escardio

Paris, France, 28 August: The echocardiographic response (reduction of left ventricular end-systolic volume) evaluated at 6 months follow-up, demonstrated to be a better predictor of long-term ...

Date : 28/08/2011
Escardio

(1) The off-label use of the drug led to worse clinical outcomes including a doubled risk of hospitalisation compared to placebo. “Valvular disease is considered the next cardiac epidemic ...

Date : 28/08/2017
Escardio

Findings from the PARADIGM-HF trial, published simultaneously in the New England Journal of Medicine, ? are extraordinarily powerful and compelling; they are destined to change the management of ...

Date : 30/08/2014
Escardio

The latest study, published today in the European Journal of Heart Failure, also found that heart failure patients whose ejection fraction is not reduced (i.e., is “preserved”) have a ...

Date : 08/03/2012
Escardio

EMBARGOED: 23 May 2016 at 08:30 CEST Florence, Italy – 23 May 2016: A subgroup analysis in heart failure patients with diabetes from the ATMOSPHERE trial has failed to show benefit and signals ...

Date : 23/05/2016